If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 342.00
Bid: 340.50
Ask: 342.00
Change: 4.00 (1.18%)
Spread: 1.50 (0.441%)
Open: 339.00
High: 342.00
Low: 334.00
Prev. Close: 338.00
VLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

18 Apr 2023 07:00

RNS Number : 4982W
Volex PLC
18 April 2023
 

 

Volex plc

 

("Volex", the "Group", or the "Company")

 

Full Year Trading Update

 

Strong organic growth with revenue and profit ahead of expectations

 

Volex (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, today issues an update on trading for the 52 weeks ended 2 April 2023 (the "Year" or "FY2023").

 

Full year trading ahead of market expectations

 

Volex has continued its positive momentum and demonstrated further progress during the Year, reflecting its compelling positions in attractive markets with strong structural growth characteristics.

 

Revenue is now expected to be at least $710 million, representing an increase of at least 15.5% compared with the prior year. Underlying operating profit is now expected to be at least $66 million, at least 17.4% higher than the prior year, with both revenue and underlying operating profit ahead of market expectations1, 2.

 

An increase in gross margins and continued cost control improvements is expected to deliver a strengthening in underlying operating margins to 9.3% (FY2022: 9.1%). The Group has delivered margins within its targeted range for three years, managing inflationary cost challenges and demonstrating the strong competitive positioning.

 

Operating free cash flow in the second half of the Year was substantially higher than the first half. After capital investment, dividend payments and acquisition consideration of approximately $46 million in the Year, pre-IFRS 16 net debt is expected to be approximately $76 million. This is a reduction of $22 million since the half year and represents a covenant leverage of 1.0x3, comfortably below the Group's target leverage corridor.

 

Continued outperformance of underlying markets provides strong momentum into FY2024

 

Against a volatile backdrop in FY2023, Volex delivered strong organic growth, ahead of its underlying markets, which has been driven by continued execution of the Group's commercial strategy which focuses on:

 

· Targeting structural growth markets - with the Electric Vehicles, Complex Industrial Technology and Medical sectors all delivering strong constant currency organic revenue growth in FY2023. Pleasingly, the adverse impact of post-pandemic demand normalisation in the Consumer Electricals sector is being largely offset by market share gains

 

· Leveraging the Group's global footprint - which is enabling the Group to benefit from heightened levels of demand in a number of territories as a result of customers re-configuring supply chains to focus on partners with high service levels and local facilities

 

· Expanding the Group's range of capabilities - through targeted investment the Group has continued to expand its offering which has led to a high level of new project wins with both new and existing customers

 

Volex is well positioned to continue investing in sustainable organic growth with a robust balance sheet and healthy cash generation. The Group has an active acquisition pipeline of value enhancing opportunities, which will support the achievement of the five-year strategy to grow revenues to $1.2 billion by the end of FY2027.

 

Nat Rothschild, Executive Chairman, said: "I am delighted with the strong organic growth performance delivered by the business during the period. We continue to deliver against the long-term, strategic growth plan that we unveiled last year and I firmly believe that Volex's diverse global footprint, ongoing investment plans and reputation for excellence will continue to drive ongoing outperformance versus our competitors. This, combined with our robust balance sheet and healthy cash generation, means that the Group is well positioned as we enter the new financial year."

 

-ENDS-

 

 

For further information please contact:

Volex plc

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

+44 (0)7747 488785

investor.relations@volex.com

 

Singer Capital Markets - Nominated Adviser & Joint Broker

Shaun Dobson

George Tzimas

+44 (0)20 7496 3000

 

HSBC Bank plc - Joint Broker

Simon Alexander

Joe Weaving

+44 (0)20 7991 8888

 

Powerscourt - Media Enquiries

James White

Nicholas Johnson 

 

+44 (0)20 7250 1446

 

Notes:

1. Underlying operating profit is before adjusting items which are one-off in nature and significant (such as restructuring costs, impairment charges or acquisition-related costs), the amortisation and impairment of acquired intangible assets and share-based payment charges. This trading update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. The Company has compiled forecasts from five analysts with current market forecasts for the 52 weeks ending 2 April 2023 for revenue to be in the range of $690.5 million to $695.0 million, with a consensus of $692.9 million, and for underlying operating profit to be in the range of $62.3 million to $64.0 million, with a consensus of $62.9 million.

 

3. Covenant leverage represents the ratio of net debt, excluding operating lease liabilities, to EBITDA excluding the impact of right of use amortisation arising on operating lease arrangements. This measure is aligned with the covenant calculations used for external debt facilities.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLDSDIDLIV
Date   Source Headline
7th Jun 201311:17 amRNSDirector/PDMR Shareholding
30th May 20139:15 amRNSDirector/PDMR Shareholding
28th May 20138:01 amRNSAppointment of new Chief Executive
28th May 20137:00 amRNSPreliminary results for year ended 31 March 2013
17th May 20137:00 amRNSHolding(s) in Company
8th May 20134:52 pmRNSVolex launches new Active Optical Cable Products
7th May 201310:47 amRNSConfirmation of Preliminary Results Date
11th Apr 20137:00 amRNSTrading Statement
14th Mar 20137:00 amRNSDirector/PDMR Shareholding
18th Feb 20134:15 pmRNSDirector/PDMR Shareholding
15th Feb 20138:59 amRNSDirector/PDMR Shareholding
13th Feb 20132:01 pmRNSDirector/PDMR Shareholding
12th Feb 20137:00 amRNSInterim Management Statement
14th Dec 20127:00 amRNSTrading Update and Board Appointments
10th Dec 20127:00 amRNSDirectorate Changes
5th Dec 201212:44 pmRNSTR-1: Notification of Major Interest in Shares
3rd Dec 20129:19 amRNSDirector PDMR Shareholding
31st Oct 20124:55 pmRNSFull Year Earnings Expectation
31st Oct 20127:00 amRNSHalf-year results
19th Sep 20128:50 amRNSDirector PDMR Shareholding
18th Sep 20127:00 amRNSTrading Update
27th Jul 201211:08 amRNSDirector PDMR Shareholding
27th Jul 20127:00 amRNSVoting Results of 2012 Annual General Meeting
26th Jul 20127:00 amRNSInterim Management Statement
29th Jun 20123:33 pmRNSDirector PDMR Shareholding
25th Jun 20123:21 pmRNSAnnual Report
31st May 20129:05 amRNSDividend currency election
29th May 201212:10 pmRNSCORRECTION - Director PDMR Shareholding
29th May 201211:45 amRNSDirector PDMR Shareholding
29th May 20127:00 amRNSPreliminary Announcement of the Group Results
12th Apr 20127:00 amRNSTrading Update
20th Mar 20123:11 pmRNSDirector Declaration
15th Feb 20124:12 pmRNSNotification of Major Interest in Shares
9th Feb 20127:00 amRNSInvestor Seminar
3rd Feb 201210:35 amRNSDirector/PDMR Shareholding
30th Jan 201212:03 pmRNSDirector/PDMR Shareholding
25th Jan 20124:46 pmRNSDirector PDMR Shareholding
19th Jan 20123:16 pmRNSDirector PDMR Shareholding
17th Jan 201211:56 amRNSDirector/PDMR Shareholding
17th Jan 20127:00 amRNSDirector PDMR Shareholding
13th Jan 20127:00 amRNSIMS for the 15 weeks ended 13 January 2012
9th Nov 20117:00 amRNSAppointment of Joint Broker
2nd Nov 20117:00 amRNSHalf Year Results
21st Oct 20114:36 pmRNSPurchase of Shares by Employees' Share Trust
21st Sep 20112:25 pmRNSTR-1: Notification of Major Interest in Shares
21st Sep 20112:23 pmRNSTR-1: Notification of Major Interest in Shares
15th Sep 20117:00 amRNSTransition to US Dollar reporting
1st Sep 20117:00 amRNSDelisting of Volex plc Preference Shares
11th Aug 20112:18 pmRNSChange of Name
29th Jul 20114:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.